NCT04388774View on ClinicalTrials.gov

Low-Dose Ketamine in Children With ADNP Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

June 8, 2021

Study Completion Date

June 8, 2021

Conditions
ADNP Syndrome
Interventions
DRUG

Ketamine

A single 40-minute intravenous infusion

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Alexander Kolevzon

OTHER

NCT04388774 - Low-Dose Ketamine in Children With ADNP Syndrome | Biotech Hunter | Biotech Hunter